Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
Status:
Not yet recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
A phase II study to assess the efficacy and safety of Surufatinib Combined With Toripalimab
and Chemotherapy as a first-line treatment in patients with advanced non-squamous non-small
cell lung cancer.